Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PT Enseval Putera Megatrading TbkISX:EPMT 88 ROC (Joel Greenblatt) % is 12.29% as of Jun. 2026, which is 34% below its 10-year median of 18.74. GuruFocus rates ISX:EPMT with a GF Score™ of 88/100 and a GF Value™ of Rp2,685.69 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 122 Medical Distribution companies, PT Enseval Putera Megatrading Tbk ranks better than 50% on this metric.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. PT Enseval Putera Megatrading Tbk's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2026 was 12.29%.
The historical rank and industry rank for PT Enseval Putera Megatrading Tbk's ROC (Joel Greenblatt) % or its related term are showing as below:
ISX:EPMT'
s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 14.79 Med: 18.74 Max: 24.51
Current: 15.71
During the past 13 years, PT Enseval Putera Megatrading Tbk's highest ROC (Joel Greenblatt) % was 24.51%. The lowest was 14.79%. And the median was 18.74%.
ISX:EPMT's ROC (Joel Greenblatt) % is ranked better than 50% of 122
companies
in the Medical Distribution industry
Industry Median: 15.56
vs ISX:EPMT: 15.71
The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ISX:EPMT vs MCK, COR, CAH: ROC (Joel Greenblatt) % Comparison
For the Medical Distribution subindustry, PT Enseval Putera Megatrading Tbk's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Enseval Putera Megatrading Tbk ROC (Joel Greenblatt) % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, PT Enseval Putera Megatrading Tbk's ROC (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where PT Enseval Putera Megatrading Tbk's ROC (Joel Greenblatt) % falls into.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:
EBIT stands for Earnings Before Interest and Taxes.
Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.
GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.
Note:
The EBIT data used here is four times the quarterly (Jun. 2026) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROC (Joel Greenblatt) % of 12.29% mean?
PT Enseval Putera Megatrading Tbk (ISX:EPMT) has a ROC (Joel Greenblatt) % of 12.29% as of Jun. 2026. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on PT Enseval Putera Megatrading Tbk and its competitors. This is 34% below median its historical median of 18.74. Over the past decade, PT Enseval Putera Megatrading Tbk's ROC (Joel Greenblatt) % has ranged from 14.79 to 24.51. According to the industry distribution chart, PT Enseval Putera Megatrading Tbk ranks #61 out of 122 companies in the Medical Distribution industry, placing it in the top 50%.
Is PT Enseval Putera Megatrading Tbk's ROC (Joel Greenblatt) % too high?
PT Enseval Putera Megatrading Tbk's current ROC (Joel Greenblatt) % of 12.29% is 34% below median its 10-year median of 18.74. Over the past 10 years, this metric has ranged from a low of 14.79 to a high of 24.51. The Medical Distribution industry median ROC (Joel Greenblatt) % is 15.56. PT Enseval Putera Megatrading Tbk's value of 12.29% is 21% below this industry median. Based on the distribution chart, PT Enseval Putera Megatrading Tbk ranks #61 out of 122 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, PT Enseval Putera Megatrading Tbk has a GF Score™ of 88/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Enseval Putera Megatrading Tbk's ROC (Joel Greenblatt) % compare to MCK and COR?
According to the Medical Distribution industry distribution chart, PT Enseval Putera Megatrading Tbk ranks #61 out of 122 companies for ROC (Joel Greenblatt) %. This puts PT Enseval Putera Megatrading Tbk in the upper half of its industry. The industry median ROC (Joel Greenblatt) % is 15.56. PT Enseval Putera Megatrading Tbk's value of 12.29% is 21% below this benchmark. Historically, PT Enseval Putera Megatrading Tbk's own ROC (Joel Greenblatt) % has ranged from 14.79 to 24.51 over the past decade. While the company's 10-year median is 18.74 vs. the industry median of 15.56, PT Enseval Putera Megatrading Tbk has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Medical Distribution company?
The median ROC (Joel Greenblatt) % among Medical Distribution companies is 15.56, based on 122 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Enseval Putera Megatrading Tbk's current ROC (Joel Greenblatt) % of 12.29% is 21% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on PT Enseval Putera Megatrading Tbk and its competitors. For the Medical Distribution industry, the median ROC (Joel Greenblatt) % is 15.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Enseval Putera Megatrading Tbk's current ROC (Joel Greenblatt) % is 12.29%, which is 34% below median its own 10-year median of 18.74. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Enseval Putera Megatrading Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Enseval Putera Megatrading Tbk (ISX:EPMT) is currently considered Modestly Undervalued. The stock's GF Value™ is Rp2,685.69, compared to a current price of Rp2,400.00 — trading 10.6% below its estimated fair value. The current ROC (Joel Greenblatt) % is 12.29%, which is 34% below median its 10-year median of 18.74 and 21% below the Medical Distribution industry median of 15.56. PT Enseval Putera Megatrading Tbk's overall GF Score™ is 88/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For PT Enseval Putera Megatrading Tbk (ISX:EPMT), the current ROC (Joel Greenblatt) % is 12.29% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Enseval Putera Megatrading Tbk (ISX:EPMT) Overvalued in 2026?
Based on GuruFocus' analysis, PT Enseval Putera Megatrading Tbk stock appears to be undervalued.
The current stock price of Rp2,400.00 is trading 10.6% below its estimated GF Value™ of Rp2,685.69.
GuruFocus considers PT Enseval Putera Megatrading Tbk to be Modestly Undervalued.
Key valuation signals for ISX:EPMT:
ROC (Joel Greenblatt) %: 12.29% (34% below median its 10-year median of 18.74)
GF Value™: Rp2,685.69 vs. price of Rp2,400.00 (10.6% below fair value)
Industry Position: 21% below the Medical Distribution median (#61 of 122)
No single metric tells the full story. See the ISX:EPMT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Enseval Putera Megatrading Tbk is a general distributor dealing in pharmaceutical products, consumer products, and medical devices. The company also acts as an agent and distributor of consumer goods, prescription medicines, non-prescription medicines, raw materials for the pharmaceutical, medical equipment, including marketing activities, veterinary medicines, cosmetics, and other industries. The company's business segments are Pharmaceuticals which generates maximum revenue; Consumer products, and Others.
88GF Score
Get the complete analysis for ISX:EPMT
ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:EPMT has been successfully added to your 
